208 related articles for article (PubMed ID: 16384911)
61. Cumulative methylation alternations of gene promoters and protein markers for diagnosis of epithelial ovarian cancer.
Xing BL; Li T; Tang ZH; Jiao L; Ge SM; Qiang X; OuYang J
Genet Mol Res; 2015 May; 14(2):4532-40. PubMed ID: 25966226
[TBL] [Abstract][Full Text] [Related]
62. Expression and promoter methylation status of OPCML and its functions in the inhibition of cell proliferation, migration, and invasion in breast cancer.
Lian B; Li H; Liu Y; Chai D; Gao Y; Zhang Y; Zhou J; Li J
Breast Cancer; 2021 Mar; 28(2):448-458. PubMed ID: 33108608
[TBL] [Abstract][Full Text] [Related]
63. High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer.
Ferguson AT; Evron E; Umbricht CB; Pandita TK; Chan TA; Hermeking H; Marks JR; Lambers AR; Futreal PA; Stampfer MR; Sukumar S
Proc Natl Acad Sci U S A; 2000 May; 97(11):6049-54. PubMed ID: 10811911
[TBL] [Abstract][Full Text] [Related]
64. CpG island promoter hypermethylation of the Ras-effector gene NORE1A occurs in the context of a wild-type K-ras in lung cancer.
Irimia M; Fraga MF; Sanchez-Cespedes M; Esteller M
Oncogene; 2004 Nov; 23(53):8695-9. PubMed ID: 15378027
[TBL] [Abstract][Full Text] [Related]
65. Reduced expression of MYO18B, a candidate tumor-suppressor gene on chromosome arm 22q, in ovarian cancer.
Yanaihara N; Nishioka M; Kohno T; Otsuka A; Okamoto A; Ochiai K; Tanaka T; Yokota J
Int J Cancer; 2004 Oct; 112(1):150-4. PubMed ID: 15305387
[TBL] [Abstract][Full Text] [Related]
66. Activation of antioxidant pathways in ras-mediated oncogenic transformation of human surface ovarian epithelial cells revealed by functional proteomics and mass spectrometry.
Young TW; Mei FC; Yang G; Thompson-Lanza JA; Liu J; Cheng X
Cancer Res; 2004 Jul; 64(13):4577-84. PubMed ID: 15231669
[TBL] [Abstract][Full Text] [Related]
67. Eicosapentaenoic acid activates RAS/ERK/C/EBPβ pathway through H-Ras intron 1 CpG island demethylation in U937 leukemia cells.
Ceccarelli V; Nocentini G; Billi M; Racanicchi S; Riccardi C; Roberti R; Grignani F; Binaglia L; Vecchini A
PLoS One; 2014; 9(1):e85025. PubMed ID: 24454781
[TBL] [Abstract][Full Text] [Related]
68. The Roles of miR-26, miR-29, and miR-203 in the Silencing of the Epigenetic Machinery during Melanocyte Transformation.
Gasque Schoof CR; Izzotti A; Jasiulionis MG; Vasques Ldos R
Biomed Res Int; 2015; 2015():634749. PubMed ID: 26618174
[TBL] [Abstract][Full Text] [Related]
69. Silent assassin: oncogenic ras directs epigenetic inactivation of target genes.
Cheng X
Sci Signal; 2008 Apr; 1(13):pe14. PubMed ID: 18385037
[TBL] [Abstract][Full Text] [Related]
70. Interplay between oncogenic K-Ras and wild-type H-Ras in Caco2 cell transformation.
Ikonomou G; Kostourou V; Shirasawa S; Sasazuki T; Samiotaki M; Panayotou G
J Proteomics; 2012 Sep; 75(17):5356-69. PubMed ID: 22800643
[TBL] [Abstract][Full Text] [Related]
71. MTH1 expression is required for effective transformation by oncogenic HRAS.
Giribaldi MG; Munoz A; Halvorsen K; Patel A; Rai P
Oncotarget; 2015 May; 6(13):11519-29. PubMed ID: 25893378
[TBL] [Abstract][Full Text] [Related]
72. Loss of opioid binding protein/cell adhesion molecule-like gene expression in gastric cancer.
Zhang N; Xu J; Wang Y; Heng X; Yang L; Xing X
Oncol Lett; 2018 Jun; 15(6):9973-9977. PubMed ID: 29805691
[TBL] [Abstract][Full Text] [Related]
73. Chronic Cigarette Smoke-Induced Epigenomic Changes Precede Sensitization of Bronchial Epithelial Cells to Single-Step Transformation by KRAS Mutations.
Vaz M; Hwang SY; Kagiampakis I; Phallen J; Patil A; O'Hagan HM; Murphy L; Zahnow CA; Gabrielson E; Velculescu VE; Easwaran HP; Baylin SB
Cancer Cell; 2017 Sep; 32(3):360-376.e6. PubMed ID: 28898697
[TBL] [Abstract][Full Text] [Related]
74. Oxidative stress-induced epigenetic changes associated with malignant transformation of human kidney epithelial cells.
Mahalingaiah PK; Ponnusamy L; Singh KP
Oncotarget; 2017 Feb; 8(7):11127-11143. PubMed ID: 27655674
[TBL] [Abstract][Full Text] [Related]
75. Inactivating mutations and X-ray crystal structure of the tumor suppressor OPCML reveal cancer-associated functions.
Birtley JR; Alomary M; Zanini E; Antony J; Maben Z; Weaver GC; Von Arx C; Mura M; Marinho AT; Lu H; Morecroft EVN; Karali E; Chayen NE; Tate EW; Jurewicz M; Stern LJ; Recchi C; Gabra H
Nat Commun; 2019 Jul; 10(1):3134. PubMed ID: 31316070
[TBL] [Abstract][Full Text] [Related]
76. Collagen and calcium-binding EGF domains 1 is frequently inactivated in ovarian cancer by aberrant promoter hypermethylation and modulates cell migration and survival.
Barton CA; Gloss BS; Qu W; Statham AL; Hacker NF; Sutherland RL; Clark SJ; O'Brien PM
Br J Cancer; 2010 Jan; 102(1):87-96. PubMed ID: 19935792
[TBL] [Abstract][Full Text] [Related]
77. Global DNA hypomethylation coupled to cellular transformation and metastatic ability.
Funaki S; Nakamura T; Nakatani T; Umehara H; Nakashima H; Okumura M; Oboki K; Matsumoto K; Saito H; Nakano T
FEBS Lett; 2015 Dec; 589(24 Pt B):4053-60. PubMed ID: 26608031
[TBL] [Abstract][Full Text] [Related]
78. Glycolic Acid Silences Inflammasome Complex Genes, NLRC4 and ASC, by Inducing DNA Methylation in HaCaT Cells.
Tang SC; Yeh JI; Hung SJ; Hsiao YP; Liu FT; Yang JH
DNA Cell Biol; 2016 Mar; 35(3):124-34. PubMed ID: 26784358
[TBL] [Abstract][Full Text] [Related]
79. Pivotal Role of the Chromatin Protein Nupr1 in Kras-Induced Senescence and Transformation.
Grasso D; Bintz J; Lomberk G; Molejon MI; Loncle C; Garcia MN; Lopez MB; Urrutia R; Iovanna JL
Sci Rep; 2015 Nov; 5():17549. PubMed ID: 26617245
[TBL] [Abstract][Full Text] [Related]
80. A genetically defined model for human ovarian cancer.
Liu J; Yang G; Thompson-Lanza JA; Glassman A; Hayes K; Patterson A; Marquez RT; Auersperg N; Yu Y; Hahn WC; Mills GB; Bast RC
Cancer Res; 2004 Mar; 64(5):1655-63. PubMed ID: 14996724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
